U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07113067) titled 'Accelerated rTMS vs. Sham for Stroke Apathy' on Aug. 02.
Brief Summary: Apathy is a common set of symptoms seen in many people following a stroke. Apathy occurs when a person has lost motivation, becomes withdrawn, and stops doing things that used to be important to them. Apathy has a large negative impact on a person's quality of life, and can also have a large impact the people who take care of them. There are currently no FDA-approved treatments to help with apathy, and other services like therapy may be difficult to access for people who have had a stroke. To address this problem, investigators are conducting a study to find out ...